revenuepurchase

199 results found.

Top Stocks matching your search for "revenue purchase"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 17, 2023

Two other drugs, each growing revenue steadily.

Mar, 13, 2023

That said, I fully expect continuing script and r... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
FSR

Fisker Inc

-28.83%

$8.15 - $5.80

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$FSR shows a strong growth in Revenue.

Mar, 21, 2023

Close to generating revenue is only positive

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 4, 2023

$TGTX shows a strong growth in Revenue.

Feb, 3, 2023

$TGTX shows a strong growth in Revenue.

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 17, 2023

Two other drugs, each growing revenue steadily.

Mar, 13, 2023

That said, I fully expect continuing script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.

Mar, 3, 2023

Two (2) other drugs, each growing revenue steadily.

Mar, 3, 2023

Two (2) other drugs, each growing revenue steadily.

Mar, 3, 2023

Two (2) other drugs, each growing revenue steadily.

Mar, 3, 2023

Two (2) other drugs, each growing revenue steadily.

Mar, 3, 2023

Two (2) other drugs, each growing revenue steadily.

Mar, 3, 2023

Two (2) other drugs, each growing revenue steadily.

Mar, 3, 2023

Two (2) other drugs, each growing revenue steadily.

Feb, 24, 2023

There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.

FSR

Fisker Inc

-28.83%

$8.15 - $5.80

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

$FSR shows a strong growth in Revenue.

Mar, 21, 2023

Close to generating revenue is only positive

Mar, 21, 2023

$FSR Easy buy before revenue.

Mar, 20, 2023

$FSR shows a strong growth in Revenue.

Mar, 20, 2023

Looking at the last year, $FSR shows a very strong growth in Revenue.

Mar, 20, 2023

Looking at the last year, $FSR shows a very strong growth in Revenue.

Mar, 19, 2023

Revenue is expected to show an annual growth rate (CAGR 2023-2027) of 17.02%, resulting in a projected market volume of US$858.00bn by 2027. 🔥🍺

Mar, 18, 2023

$FSR: The Revenue has grown by 232.04% in the past year.

Mar, 18, 2023

$FSR: The Revenue has grown by 232.04% in the past year.

Mar, 17, 2023

Revenue and a profitable ocean program is coming.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 4, 2023

$TGTX shows a strong growth in Revenue.

Feb, 3, 2023

$TGTX shows a strong growth in Revenue.

Jan, 29, 2023

Add beginning revenue stream, BO rumors, a steady stream of upgrades.

Dec, 30, 2022

$TGTX This gonna be amazing guys after they sell their product Lets say 50.000 usd for the dose and they sell 500 a month Make the math and tell me how revenue they will get every quarter

Dec, 30, 2022

$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.

Dec, 30, 2022

This is not some get rich scheme, this is a solid biotech company with an approved product that will bring in billions in revenue.